Veloxa Chewable Tablets for Dogs
Veloxa Chewable Tablets for Dogs
Authorised
- Praziquantel
- Pyrantel
- Febantel
Product identification
Medicine name:
Veloxa Chewable Tablets for Dogs
Veloxa μασώμενα δισκία για σκύλους
Active substance:
- Praziquantel
- Pyrantel
- Febantel
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Praziquantel50.00milligram(s)1.00Tablet
-
Pyrantel50.00milligram(s)1.00Tablet
-
Febantel150.00milligram(s)1.00Tablet
Pharmaceutical form:
-
Chewable tablet
Withdrawal period by route of administration:
-
Oral use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AA51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Package description:
- PVC/Aluminium/Polyamide blister-forming laminate with aluminium lidding foil containing 2 or 8 chewable tablets. Box containing 52 blister strips of 2 chewable tablets (104 chewable tablets)
- PVC/Aluminium/Polyamide blister-forming laminate with aluminium lidding foil containing 2 or 8 chewable tablets. Box containing 13 blister strips of 8 chewable tablets (104 chewable tablets)
- PVC/Aluminium/Polyamide blister-forming laminate with aluminium lidding foil containing 2 or 8 chewable tablets. Box containing 1 blister strip of 2 chewable tablets (2 chewable tablets)
- PVC/Aluminium/Polyamide blister-forming laminate with aluminium lidding foil containing 2 or 8 chewable tablets. Box containing 2 blister strips of 2 chewable tablets (4 chewable tablets)
- PVC/Aluminium/Polyamide blister-forming laminate with aluminium lidding foil containing 2 or 8 chewable tablets. Box containing 1 blister strips of 8 chewable tablets (8 chewable tablets)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Lavet Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
- Lavet Pharmaceuticals Ltd.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 77380/16/21-08-2017/K-0198701
Date of authorisation status change:
Reference member state:
-
Hungary
Procedure number:
- HU/V/0116/001
Concerned member states:
-
Austria
-
Belgium
-
Finland
-
France
-
Germany
-
Greece
-
Ireland
-
Italy
-
Luxembourg
-
Netherlands
-
Norway
-
Portugal
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: